Molecular genetics of von Willebrand disease

Thrombosis and Haemostasis

Volumn 82, Issue 2, 1999, Pages 585-591

  Ginsburg, David ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

CLINICAL FEATURE; CONFERENCE PAPER; DISEASE SEVERITY; GENE DELETION; GENE FREQUENCY; HUMAN; HUMAN CELL; MISSENSE MUTATION; MOLECULAR GENETICS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VON WILLEBRAND DISEASE;

EID: 0032725346     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615884     Document Type: Conference Paper

References (47)

1. von Willebrand EA. Hereditär Pseudohemofili. Finska Läkarsällskapetes Handl. 1926;67:7-112.
2. Ginsburg D. Hemophilia and other inherited disorders of hemostasis and thrombosis. In: Rimoin DL, Connor JM, Pyeritz RE, Emery AEH., eds. Emery and Rimoin's Principles and Practice of Medical Genetics. New York: Churchill Livingstone; 1997:1651-1676.
3. Wagner DD. Storage and secretion of von Willebrand factor. In: Ruggeri ZM, Zimmerman TS., eds. Coagulation and Bleeding Disorders: The role of Factor VIII and von Willebrand factor. New York and Basel: Marcel Dekker; 1989:161-180.
4. Bowie EJW, Solberg LA, Jr., Fass DN, Johnson CM, Knutson GJ, Stewart ML, Zoecklein LJ. Transplantation of normal bone marrow into a pig with severe von Willebrand's disease. J Clin Invest. 1986;78:26-30.
5. Nichols TC, Samama CM, Bellinger DA, Roussi J, Reddick RL, Bonneau M, Read MS, Bailliart O, Koch GG, Vaiman M, et al. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: Effect on arterial thrombosis in chimeras. Proc Natl Acad Sci USA. 1995;92:2455-2459.
6. Yamamoto K, de Waard V, Fearns C, Loskutoff DJ. Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo. Blood. 1998;92:2791-2801.
7. Ruggeri ZM, Ware J, Ginsburg D. von Willebrand factor. In: Loscalzo J, Schafer AI., eds. Thrombosis and Hemorrhage. Boston: Blackwell Scientific Publications; 1998:337-364.
8. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost. 1994;71:520-525
9. Lyons SE, Bruck ME, Bowie EJW, Ginsburg D. Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem. 1992;267:4424-4430.
10. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA. 1990;87:6306-6310.
11. Tsai H-M, Sussman II, Ginsburg D, Lankhof H, Sixma JJ, Nagel RL. Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: Inhibition by doxycycline and by monoclonal antibody VP-1. Blood. 1997;89:1954-1962.
12. Furlan M, Robles R, Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood. 1996;87:4223-4234.
13. Ginsburg D, Sadler JE. von Willebrand Disease: A database of point mutations, insertions, and deletions. Thromb Haemost. 1993;69:177-184.
14. Holmberg L, Dent JA, Schneppenheim R, Budde U, Ware J, Ruggeri ZM. von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure. J Clin Invest. 1993;91:2169-2177.
15. Mazurier C. von Willebrand disease masquerading as haemophilia A. Thromb Haemost. 1992;67:391-396.
16. Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS. A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. J Biol Chem. 1987;262:8443-8446.
17. Schneppenheim R, Budde U, Krey S, Drewke E, Bergmann F, Lechler E, Oldenburg J, Schwaab R. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1. Thromb Haemost 1996;76:598-602.
18. Nichols WC, Ginsburg D. von Willebrand disease. Medicine. 1997;76:1-20.
19. Zhang ZP, Blombäck M, Nyman D, Anvret M. Mutations of von Willebrand factor gene in families with von Willebrand disease in the Aland Islands. Proc Natl Acad Sci USA. 1993;90:7937-7940.
20. Mohlke KL, Nichols WC, Rehemtulla A, Kaufman RJ, Fagerstrom HM, Ritvanen KL, Kekomaki R, Ginsburg D. A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processing. Br J Haematol. 1996;95:184-191.
21. Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand's disease. I. Phenotypic variation within families. Blood. 1979;54:117-145.
22. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood. 1987;69:454-49.
23. Mohlke KL, Ginsburg D. von Willebrand disease and quantitative deficiency of von Willebrand factor. J Lab Clin Med. 1997;130:252-261.
24. Nosek-Cenkowska B, Cheang MS, Pizzi NJ, Israels ED, Gerrard JM. Bleeding/bruising symptomatology in children with and without bleeding disorders. Thromb Haemost. 1991;65:237-241.
25. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395-424.
26. Eikenboom JCJ, Matsushita T, Reitsma PH, Tuley EA, Castaman G, Briet E, Sadler JE. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. Blood. 1996;88:2433-2441.
27. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand Disease. Blood. 1987;69:1691-1695.
28. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet. 1985;37:89-101.
29. Martin N, Boomsma D, Machin G. A twin-pronged attack on complex traits. Nat Genet. 1997;17:387-392.
30. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516-1517.
31. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell. 1993;75:631-639.
32. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell. 1993;73:469-485.
33. Bellamy R, Ruwende C, Corrah T, McAdam KPWJ, Whittle HC, Hill AVS. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med. 1998;338:640-644.
34. Ginsburg D, Bowie EJW. Molecular genetics of von Willebrand disease. Blood. 1992;79:2507-2519.
35. Denis C, Methia N, Frenette PS, Rayburn H, Ullman-Cullere M, Hynes RO, Wagner DD. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA. 1998;95:9524-9529.
36. Sweeney JD, Novak EK, Reddington M, Takeuchi KH, Swank RT. The RIIIS/J inbred mouse strain as a model for von Willebrand disease. Blood. 1990;76:2258-2265.
37. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72:971-983.
38. Nichols WC, Cooney KA, Mohlke KL, Ballew JD, Yang A, Bruck ME, Reddington M, Novak EK, Swank RT, Ginsburg D. von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene. Blood. 1994;83:3225-3231.
39. Mohlke KL, Nichols WC, Westrick RJ, Novak EK, Cooney KA, Swank RT, Ginsburg D. A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11. Proc Natl Acad Sci USA. 1996;93:15352-15357.
40. Mohlke KL, Purkayastha AA, Westrick RJ, Ginsburg D. Comparative mapping of distal murine chromosome 11 and human 17q21.3 in a region containing a modifying locus for murine plasma von Willebrand factor level. Genomics. 1998;54:19-30.
41. Mohlke KL, Purkayastha AA, Westrick RJ, Smith PL, Petryniak B, Lowe JB, Ginsburg D. Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase. Cell. 1998;96:111-120.
42. Smith PL, Lowe JB. Molecular cloning of a murine N-acetylgalactosamine transferase cDNA that determines expression of the T lymphocyte-specific CT oligosaccharide differentiation antigen. J Biol Chem. 1994;269:15162-15171.
43. a blood group carbohydrate structure in human gastrointestinal mucosa and cancer. Int J Cancer. 1996;67:626-631.
44. Ponder BAJ, Wilkinson MM. Organ-related differences in binding of Dolichos biflorus agglutinin to vascular endothelium. Dev Biol. 1983;96:535-541.
45. Ponder BAJ, Festing MFW, Wilkinson MM. An allelic difference determines reciprocal patterns of expression of binding sites for Dolichos biflorus lectin in inbred strains of mice. J Embryol Exp Morph. 1985;87:229-239.
46. Sodetz JM, Paulson JC, McKee PA. Carbohydrate composition and identification of blood group A, B, and H oligosaccharide structures on human Factor VIII/von Willebrand factor. J Biol Chem. 1979;254:10754-10760.
47. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology. 1993;3:97-130.